Tutter18 - 100% agree as I kept trying to focus on SCRC and only you got me Tut ...appreciate it , but all my previous posts were still me and SCRC is our bean stock.....yep yep ..up up and away with many limbs and pauses for growth and a few limbs may fall ( selloffs ) as new ones start to take hold ( growth ) . Over time , these prices will be ridiculously low , and all the naysayers will hate the taste of crow feathers they choke down . Many people feel or felt a huge loss from the .90 levels and Celts did also . We all have our opinions but in the end we are all still here and many forget the entity that caused the pain . Lets all be sure this upward trend is legit now and soon back to the .40 levels we had before the last fast rise and fall....I sure as hell hope everyone sees where I am coming from and lets all keep this group moving positively forward as I wont ever back down or shy from my opinion . We may not all agree all the time but we can all agree on one thing SCRC WILL BE A MONSTER OVER TIME ......enough said ......
Tutter18 - 100% agree as I kept trying to focus on SCRC and
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Exploring Murphy Oil Inc.'s Price-to-Earnings Insights
Understanding Murphy Oil Inc.'s Recent Market Performance Currently, Murphy Oil Inc. (NYSE: MUR) shares are valued at $30.88, exhibiting a minor rise of 0.06% in today's trading session. Observing the stock’s journey over the last month, we've seen a significant increase of 6.77%. However, when we take a closer look at the past year, the stock has unfortunately dropped...
Continue Reading
Marco Pharma: 35 Years of Principle Over Profits
Keeping Principles Alive in a Competitive Market In an industry where folks often chase the latest trend like seagulls after a fish fry, Marco Pharma International stands its ground on principles rather than profits. It's rare to see a company, especially in the natural health sector, keeping its roots this deep for 35 years. And they're not just talking about it—this...
Continue Reading
Rakovina Therapeutics Unveils AI-Enhanced ATR Inhibitors Breakthrough
Rakovina Therapeutics Presents AI-Developed ATR Inhibitors Rakovina Therapeutics Inc. (TSXV: RKV) has made a significant impact at a recent international conference dedicated to cancer therapeutics. The conference gathered numerous leaders in the field, creating an excellent platform to unveil groundbreaking research. Presenting their innovative findings, Rakovina...
Continue Reading
Elon Musk Critiques FCC's Denial of Starlink Subsidy While Aiding Disaster Recovery
Elon Musk Critiques FCC's Decision on Starlink Subsidy Elon Musk, the visionary CEO of SpaceX, has voiced his discontent over the FCC's recent ruling that denied approximately $885 million in subsidies to Starlink, the company's satellite internet service. Musk described this decision as "contemptible political lawfare," coinciding with FEMA's deployment of Starlink...
Continue Reading
Assessing the Resilience of American Consumers Amid Challenges
Understanding the Current Landscape of American Consumers The state of the American consumer remains resilient despite facing numerous challenges, as reported by Barclays in its recent analysis. The approach to consumer spending in the latest quarter reflects a balancing act, with buyers maneuvering through both advantageous conditions and potential obstacles. Positive...
Continue Reading